Table 2.
Relative Risk of All‐Cause Mortality, According to AT/ET
| Variable | All‐cause mortality | ||
|---|---|---|---|
| Outcome under conservative management | HR (95% CI) | P value | |
| Univariate analysis | |||
| AT/ET per increment of 0.01 | 1.09 (1.04–1.16) | <0.001 | |
| AT/ET ≤0.35 | Reference | ||
| AT/ET >0.35 | 2.44 (1.39–4.29) | <0.001 | |
| Multivariable model (n=230)* | |||
| AT/ET per increment of 0.01 | 1.11 (1.04–1.18) | 0.002 | |
| AT/ET ≤0.35 | Reference | ||
| AT/ET >0.35 | 3.29 (1.70–6.39) | <0.001 | |
| Outcome under medical and/or surgical management | Adjusted HR (95% CI) | P value | |
| Univariate analysis | |||
| AT/ET per increment of 0.01 | 1.06 (1.01–1.11) | 0.018 | |
| AT/ET ≤0.35 | Reference | ||
| AT/ET >0.35 | 1.89 (1.16–3.08) | 0.010 | |
| Multivariable model without AVR (n=347)* | |||
| AT/ET per increment of 0.01 | 1.08 (1.02–1.14) | 0.009 | |
| AT/ET ≤0.35 | Reference | ||
| AT/ET >0.35 | 2.34 (1.36–4.03) | 0.002 | |
| Multivariable model with AVR (n=347) † | |||
| AT/ET per increment of 0.01 | 1.09 (1.03–1.15) | 0.004 | |
| AT/ET ≤0.35 | Reference | ||
| AT/ET >0.35 | 2.54 (1.47–4.37) | <0.001 | |
AT/ET indicates ratio of acceleration time/ejection time; AVR, aortic valve replacement; and HR, hazard ratio.
Multivariable model is adjusted for age, sex, systolic blood pressure, Charlson comorbidity index (without including age), history of atrial fibrillation, peak aortic jet velocity, left ventricular stroke volume index, and left ventricular ejection fraction.
Model is adjusted for covariates included in the model without AVR and AVR as time‐dependent covariate.